The global ophthalmic surgical devices market size is anticipated to reach USD 12.75 billion by 2026, registering a CAGR of 4.8% during the forecast period. Rising prevalence of cataract is one of the key factors fueling this market. The World Health Organization (WHO) defines cataract as “clouding of the lens of the eye which impedes the passage of light”. The WHO estimates that currently there are approximately 18 million around the world that are blind in both eyes due either to improper surgery or inaccessibility to advanced procedures. While this eye condition mostly occurs as a person ages, the WHO claims that other risk factors such as diabetes, exposure to UV light, and smoking are fast emerging as major grounds for cataract.

Visit: https://www.fortunebusinessinsights.com/ophthalmic-surgical-devices-market-102054

Moreover, the International Agency for the Prevention of Blindness (IAPB) states that blindness from cataract is around 5% in developed countries and 50% in developing and underdeveloped nations. Increasing demand for ocular treatments from emerging economies is, therefore, expected to lead the ophthalmic surgical devices market trends in the upcoming decade. 

Industry Developments:

• August 2019: New World Medical, a renowned company in ophthalmological devices, launched its brand new glaucoma drainage tool,  Ahmed ClearPath, in the US. The device consists of a flexible plate designed to align with the curvature of the eye and anteriorly placed suture fixation points for efficient drainage.
• July 2019: The Irish pharmaceutical giant, Allergan, announced that its New Drug Application for the company’s Bimatoprost Sustained-Release has been accepted by the US FDA. If successful, the product would be the first-of-its-kind biodegradable implant for treating patients with glaucoma or ocular hypertension.

Growing Number of Aged People Worldwide to Prove Beneficial for the Market

According to the WHO, aging is the primary reason for the development of eye diseases and conditions. The condition develops slowly as the strength of the lens in the eye deteriorates with age and diminishes vision. Therefore, as world population ages, the incidence of age-related ocular disorders is likely to rise. According to the Department of Economic and Social Affairs of the UN, by 2050, there will be close to 2.1 billion people crossing the age of 60. Estimates released by AGS Health in Aging Foundation reveal that 20% of the adults above 60 years of age developed cataract in one or both eyes in 2019. Further, Mayo Clinic reports that glaucoma, which occurs due to damaged optic nerve in people over the age of 60, is one of the top causes of blindness in the world. Thus, growing global geriatric population would boost the ophthalmic surgery devices market growth.

The global pet insurance market size is projected to reach USD 11.25 billion by 2026. The increasing pet adoption in leading countries across the world will have a direct impact on the growth of the market. According to a report published by Fortune Business Insights, titled “Pet Insurance Market Size, Share & Industry Analysis, By Policy Coverage Type (Accident & Illness, Accident Only, Others), By Animal Type (Dog, Cat, Others), By Provider (Public, Private) and Regional Forecast, 2019-2026,” the market was worth USD 6.05 billion in 2018. Driven by flexibility in product offerings, the market will exhibit a CAGR of 8.0% during the forecast period, 2019-2026.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/pet-insurance-market-101956

The pet insurance market will benefit from the increasing pet adoption in leading countries across the world. Pet insurance refers to a policy that covers medical as well as accidental factors that is associated with the pets. The emphasis on the well-being and health of pets, by private as well as government organizations will create several growth opportunities.

The presence of several private organizations offering premium insurance policies will have a positive impact on the growth of the market in the forthcoming years. Several companies are focused on offering novel services as well as concessions in a bid to establishing a stronghold in the market. These factors will aid the growth of the market in the coming years.

Increasing Number of Company Mergers and Collaborations to Aid Market Growth

The report encompasses several factors that have contributed to the growth of the market in recent years. It highlights a few of the leading market drivers and analyzes their impact on the market. Among all factors, the increasing number of company mergers and collaborations have had a positive impact on market growth. In October 2019, Petplan, a leading pet insurance provider, announced that it has been acquired by Warnbug Pincus. Warnbug is a leading private equity firm that mainly focuses on growth-oriented investing. With this acquisition, the company will look to outperform its counterparts and in doing so, establish a strong presence in the market. The report highlights a few of the other company mergers that have graced the market in recent years and gauges their impact on the market.

The global anti-inflammatory biologics market size is expected to reach USD 149.80 billion by 2027, exhibiting a CAGR of 11.0% during the forecast period. The indication of an inflammatory surplus in patients with COVID-19 along with plentiful neutrophils and macrophages will revivify growth prospects for the anti-inflammatory biologics market share during the forecast period.

The ongoing trials for anti-tumor necrosis factor (TNF) antibodies in severe cases of autoimmune inflammatory disease such as rheumatoid arthritis, inflammatory bowel disease, or ankylosing spondylitis will aid the speedy expansion of the market during the forecast period, mentioned by Fortune Business Insights, in a report, titled “Anti-Inflammatory Biologics Market Size, Share & Industry Analysis, By Drug Class (Anti-Tumor Necrosis Factor (TNF), Interleukin Antagonists, Janus Kinase (JAK) Inhibitors, Others), By Application (Rheumatoid Arthritis, Psoriasis, and Others), By Route of Administration (Oral and Injection (Subcutaneous and Intravenous)), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027” the market size stood at USD 64.84 billion in 2019.

Please visit: https://www.fortunebusinessinsights.com/anti-inflammatory-biologics-market-102733

Ongoing Trails for Anti-Tumour Necrosis Factor Therapy to Benefit COVID-19 Patients

The increasing R&D investments by major players for the development of biologics will promote market growth in the forthcoming years. The rising number of deaths from coronavirus (COVID-19) has steered pharmaceutical companies to invest in potential drug candidates. The growing prominence of TNF in acute inflammatory reactions will have a positive impact on the market. Similarly, the ongoing research for anti-TNF therapy in patients with COVID-19 for counteraction and prevention will tremendously influence the market in the forthcoming years.

Moreover, the advent of novel biological therapies and monoclonal antibodies by biopharma giants will facilitatethe healthy growth of the marketduring the forecast period. For instance, in December 2019, UCB S.A, a multinational biopharmaceutical company announced positive results from the phase 3 clinical study of Bimekizumab for the treatment of psoriasis.  Also, the escalation in applications of existing biologics for rare anti-inflammatory diseases such as lupus, diffuse systemic sclerosis, and others will enhance business scenarios of the market

The Dental Crowns and Bridges Market is likely to gain momentum from the rising usage of digital dentistry. Presently, masses at are choosing various digital equipment, such as milling machines, computer software, scanners, and radiological devices for restorative and preventive dentistry. Teeth structures are also being customized by using CAD/CAM, as well as 3D printing technologies. This information is published by Fortune Business Insights™ in a recent report, titled, “Dental Crowns and Bridges Market Size, Share & Industry Analysis, By Type (Crowns, and Bridges), By Material (Ceramics, Porcelain Fused to Ceramics, and Metals), By End User (Dental Hospitals & Clinics, Dental Laboratories, and Others), and Regional Forecast, 2019-2026.” The report further mentions that the Dental Crowns and Bridges Market size was USD 2.85 billion in 2018 and is projected to reach USD 4.56 billion by 2026, exhibiting a CAGR of 6.1% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/dental-crowns-and-bridges-market-102714

Increasing Prevalence of Tooth Decay to Bolster Growth

One of the major growth drivers of the market includes the rising incidence of tooth decay and periodontal diseases. Dental caries is considered to be a significant burden and it is capable of affecting people throughout their lives, causing discomfort, disfigurement, and pain. Hence, it requires immediate medical attention. The World Health Organization stated that worldwide, approximately 3.9 billion people were affected in 2018 by oral diseases. These are mainly occurring because of poor oral hygiene, as well as rising consumption of alcohol, tobacco, sugar, and practicing an unhealthy diet. However, these dental procedures involve spending hefty amount of money. It may hinder the dental caps & bridges market growth during the forthcoming years.

Ability to Provide Lucent Finish will Drive Growth of the Ceramics Segment

Based on material, the market is grouped into metals, porcelain fused to metals, and ceramics. Out of these, the ceramics segment held 55.2%Dental Crowns and Bridges Market share in 2018 and is anticipated to remain dominant throughout the forecast period. This growth is attributable to the ability of ceramics to provide an attractive lucent finish to bridges and crowns. Also, they possess a similar aesthetic appearance to the original tooth. They are also strong and tough in nature and therefore, can be customized as per the patient’s requirement.

The global revenue cycle management (RCM) market size is expected to reach USD 258.16 billion, registering a CAGR of 13.0% during the forecast period. RCM process enables hospitals to streamline the patient revenue collection procedure. With RCM, hospitals can design and implement their methods for speedy collection. Fortune Business Insights™ has presented this information in an upcoming report titled, “Revenue Cycle Management (RCM) Market, 2020-2027”. The market size stood at USD 96.27 billion in 2019.

According to the report, the RCM market is gaining swift traction due to several reasons. For instance, many countries are witnessing an unparalleled inflow of patients due to the COVID-19 pandemic. The health crisis has almost brought the hospital industry to a near-collapse. This has put tremendous stress on the healthcare industry, and they are therefore relying on RCM services to ensure adequate revenue collection.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/revenue-cycle-management-market-100275

COVID-19 Impact-

The global pandemic has wreaked unprecedented havoc on several industries and markets. Healthcare systems are on the verge of collapsing in many nations. The healthcare industry is under tremendous stress due to the massive inflow of patients. Efforts are being made to strengthen the medical infrastructure worldwide. The negative impact of the COVID-19 crisis is expected to gradually fade away as economies are trying to wade their way through the pandemic. It is uncertain to say how long the situation may persist this way. Nonetheless, our research report’s in-depth analysis will help you gain an exhaustive understanding of this niche market.

Integration of Artificial Intelligence in RCM Services to Augment Market Growth

The adoption of RCM services is rising in the global market. RCM provides a spectrum of IT products like advanced predictive analysis, automated patient collection systems, and business intelligence tools. This helps the healthcare providers in streamlining their revenue collection processes and is driving the growth of the RCM market. The incorporation of artificial intelligence in RCM is expected to further swell the market growth as it helps in automating processes and optimizing clinical outcomes. Most recently, Healthcare Financial Management Association (HFMA) revealed in a survey that around 75% of leaders in the healthcare industry are focusing on employing Artificial intelligence in RCM. The launch of Electronic Health Records (EHRs) has transformed the patient data collection, analysis, and reporting process in healthcare organizations and is expected to benefit the RCM market. Future technological advancements are expected to create further growth opportunities for the market.

The global respiratory syncytial virus (RSV) therapeutics market size is estimated to showcase potential growth owing to its increasing adoption against the prevention and treatment of the disease, observes Fortune Business Insights™ in an upcoming report, titled, “Respiratory Syncytial Virus (RSV) Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Prophylaxis and Treatment), By End-user (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy) and Regional Forecast, 2020-2027.” The respiratory syncytial virus (RSV) therapeutics market stood at USD 1,111.3 million in 2019. It is projected to grow from USD 609.2 million in 2020 to USD 4,003.4 million in 2027 at a CAGR of 30.9% in the forecast period.

Get Sample Report On Global Respiratory Syncytial Virus (RSV) Therapeutics Market: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/respiratory-syncytial-virus-rsv-therapeutics-market-104668

High Production Scale to Hinder Growth Opportunities in Global Pharmaceutical Space

The COVID-19 contagion is expected to drive the global pharmaceutical industry. Enterprises across the world along with governments from several nations are contributing to the development and distribution of the vaccine. However, the scale at which the production is assumed to take place is a major challenge for most of the renowned players. At Fortune Business Insights™, we are providing actionable insights by closely studying multiple aspects of the current scenario. We are also offering firsthand information on various market trends through our comprehensive research reports.

New Product Launches from Key Players Helped Prophylaxis Segment Hold Largest Share In 2019

Based on drug class, the prophylaxis segment led the market with the largest share in 2019. Potential approvals and launch of maternal vaccines by companies including Pfizer and GSK are estimated to help the segment further dominate the market during the forecast timeframe. Based on end-user, the hospital pharmacy segment dominated the global market owing to the high demand for healthcare professionals for the existing treatment and prevention options.

The Global Nurse Call Systems Market is anticipated to showcase notable growth owing to the reduction in the number of patient to nurse ratio. According to a report by Fortune Business Insights, titled, “Nurse Call Systems Market Size, Share & Industry Analysis, By Technology (Wired, Wireless), By Product (Basic Button Based Systems, Mobile Integrated Systems, IP Based Systems, Others), By End-user (Hospitals and Clinics, Assisted Living and Nursing Centres, Home Care Setting, Others), and Regional Forecast, 2019-2026,” the global nurse call systems market size was valued at USD 1.18 Billion in 2018. However, the global market is projected to reach USD 2.78 Billion by 2026, exhibiting a CAGR of 11.4% during the forecast period.

Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/nurse-call-systems-market-100274

Some of the Main Key Players Covered in the Nurse Call Systems Market Report:

• Ascom
• Hillrom
• Johnson Controls
• Jeron Electronic Systems Inc.s
• BEC GmbH
• Azure Healthcare Services, LLC
• Cornell Communications, Inc
• TekTone Healthcare Communications
• GD Systems

Increasing Incidence of Chronic Disorders to Aid in the Growth of Hospital Segment

In terms of end user, the global nurse call systems market is grouped into home care settings, assisted living and nursing centers, hospitals and clinics, and others. The report mentions that hospitals are expected to generate the highest global nurse call systems market revenue in the forthcoming years. It would occur as the nurses in hospitals depend upon nurse call systems for workforce management, emergency management, and monitoring of patients’ health. Also, hospitals possess high patient pool who are in persistent need for general healthcare. Additionally, the rising prevalence of chronic diseases are leading to hospitalizations. It will contribute to the global nurse call systems market growth in the coming years.

The other healthcare facilities like a nursing home and assisted living centers are also estimated to experience considerable growth during the forecast period owing to the rising geriatric population combined with rising prevalence of neurological disorders in this patient population. In recent years there is a growing trend in elderly population preferring home care treatment. However, the home care setting in global nurse call system market held a lower market share.

The global thin film drugs market size is projected to reach USD 16.27 billion in 2028. Fortune Business Insights™ published this information in a new study, titled, “Thin Film Drugs Market, 2021-2028.” The study further mentions that the market stood at USD 7.35 billion in 2020. It is expected to showcase a CAGR of 10.5% in the forecast period between 2021-2028. The surging geriatric population across the globe is anticipated to affect growth positively. As per the United Nations, in 2017, the global old age population was 962 million. It is estimated to double by the end of 2050 and reach 2.1 billion. Hence, the prevalence of Alzheimer’s and Parkinson’s diseases will also increase rapidly, thereby accelerating the demand for thin film drugs.

please visit: https://www.fortunebusinessinsights.com/thin-film-drugs-market-104883

Rising Focus on Developing COVID-19 Vaccine to Impact Growth Negatively

Several pharmaceutical companies are currently focusing on inventing a vaccine that would fight against the COVID-19 pandemic. It has resulted in disruptions of research and development activities associated with thin film drugs in various parts of the world. It is expected to hamper growth of the market in the near future. Our research reports will help you find the best strategy to uplift your businesses amid this pandemic.

Retail Pharmacy Segment to Dominate Backed by Easy Availability of Drugs

Our analysts have segmented the market on the basis of product, disease indication, distribution channels, and geography. By product, it is fragmented into transdermal film drugs and oral thin film (OTF) drugs. Based on the disease indication, it is divided into opioid dependence, migraine, schizophrenia, and others. Below is a glimpse of the distribution channel criterion:

• By Distribution Channels: it is segregated into hospital pharmacy, retail pharmacy, and others. Amongst these, the retail pharmacy segment dominated in 2020 by earning the largest thin film drugs market share. This growth is attributable to the easy availability of thin film drug delivery models in retail pharmacies because of their possession of generic molecules.

The launch of the vaccine named, Vanguard CIV H3N2/H3N8 Vaccine, was announced in December 2017 by Zoetis. This was the most recent vaccine in the list of the company’s canine influenza vaccine portfolio. Such initiatives taken by companies towards the launch of vaccines to protect animals from various diseases is promoting the growth of the global veterinary vaccines market, predicts Fortune Business Insights in their new report.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/veterinary-animal-vaccines-market-101532

Fortune Business Insights foresees the global market for veterinary vaccines to rise because of the increasing number of pet adopters worldwide. In a report, titled “Veterinary Vaccines Market Size, Share & Industry Analysis, By Product (Inactivated, Live Attenuated, Recombinant, Others), By Animal (Companion, Livestock), By Route of Administration (Oral, Parenteral, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others) and Regional Forecast, 2019-2026” it offers an overview of the market, highlighting the key growth drivers and potential restraints. It also provides recommendations to help market players gain competitive edge.

According to the report, the market is anticipated to rise from a value of USD 9.75 Billion in 2018 to USD 16.01 Billion by 2026. The forecast period is set from 2019 to 2026 and the market is expected to rise at a CAGR of 6.4%.

The global veterinary vaccines market is segmented on the basis of product, animal, and route of administration, distribution channel, and geography. Among these, the parental animal vaccines segment will earn the highest revenue in the forecast duration with respect to route of administration. This is owing to the fact that parental animal vaccines are among the most traditional and common forms of vaccinations. On the other side, the companion animal segment is prognosticated to grow at rapid CAGR in the forecast period, with respect to animal. This is attributable to the rise in number of pet ownership on a worldwide basis.

Rise in Disposable Income to Help Asia Pacific Market Grow Rapidly

The global veterinary vaccines market was dominated by North America with a revenue generation of US$ 2.97 billion in 2018 AND Fortune Business Insights predicts this region to continue its dominance in the forecast period as well owing to the rapid adoption of efficient veterinary vaccines. This, accompanied by the use of technologically advanced vaccine delivery across all regions is anticipated to help North America remain dominant.

The global cosmeceuticals market size is projected to reach USD 73.73 billion by the end of 2026. The increasing investment in the R&D of newer products will have a massive impact on the growth of the market in the coming years. According to a report published by Fortune Business Insights, titled “Cosmeceuticals Market Size, Share & Industry Analysis, By Product (Skin Care, Hair Care, Injectable and Others), By Distribution Channels (Pharmacy/Drug Stores, Online Stores, and Others), and Regional Forecast, 2019-2026,” the market was worth USD 37.41 billion and will exhibit a CAGR of 8.9% during the forecast period, 2019-2026.

Visit: https://www.fortunebusinessinsights.com/cosmeceuticals-market-102521

Cosmeceuticals are products that are inclusive of normal cosmetics and a few pharmaceuticals. The primary purpose behind the use of these products is the need for enhancing body appearance. These functions are carried out by the antioxidants used in the cosmeceuticals products. Recent advances in manufacturing as well as ingredients of these products will bode well for the market in the forthcoming years. The increasing adoption of visually appealing aesthetics, coupled with the availability of cosmeceuticals at a low cost, will have a positive impact on the growth of the market in the coming years. Additionally, the increasing number of regulatory approvals has boded well for the market in recent years and will continue to have a positive impact on the market in the coming years.

North America to Emerge Dominant; Increasing Investments by Major Companies Will Aid Market Growth

The report analyses the ongoing blood screening market trends across North America, Latin America, Asia Pacific, and the Middle East and Africa. Among these regions, the market in Asia Pacific holds the highest market share, driven by the huge demand for these products in several countries across this region. As of 2018, the market in Asia Pacific was worth USD 18.32 billion and this value is projected to increase further in the coming years. Besides Asia Pacific, the market in North America and the Middle East and Africa will witness moderate growth in the coming years.